Cervical cancer screening recommendations
January is Cervical Cancer Awareness Month. Each year, more than 11,000 new cases of cervical cancer are diagnosed in the U.S., according to the Centers for Disease Control and Prevention.
Jan 11, 2024
0
31
Urogenital Diseases: News and Research on Uterine Neoplasms
MeSH tree: C12.050.351.500.852.762
Cancer test shows promise for bringing the benefits of immunotherapy to more patients
Immunotherapy is a highly effective treatment for patients whose cancers harbor mismatch repair deficiency, and a new study identifies more cancer patients who could benefit from this form of therapy. Investigators from Brigham ...
Dec 29, 2023
0
102
Endometrial cancer: New insights into a deadly disparity
Endometrial cancer—which develops in the lining of the uterus (womb) and is sometimes called uterine cancer—is on the rise in the U.S. In 1987, there were 35,000 cases annually. That number has nearly doubled in 2023 to more ...
Dec 20, 2023
0
46
Organoids study discovers promising treatment for deadly uterine cancer
QUT scientists have discovered a promising new therapy for a deadly type of endometrial cancer that has a poor prognosis if the cancer spreads or returns after initial treatment, a plight that affects 15%–20% of endometrial ...
Dec 13, 2023
0
42
White women overrepresented in gynecologic cancer trials
White women are disproportionately represented in clinical trials for gynecologic cancers, according to a study published online Dec. 7 in JAMA Network Open.
Dec 12, 2023
0
35
Risk of dying from cancer in some poorer districts of England over 70% higher than wealthy districts, study suggests
The risk of dying from the 10 forms of cancer with the largest death toll for men and women varies massively depending on the district in England where people live, according to a study published in The Lancet Oncology.
Dec 11, 2023
0
34
Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer
Published in The Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030) show that adding immune checkpoint inhibitor atezolizumab to standard of care with bevacizumab and ...
Dec 4, 2023
0
36
Researchers optimize cervix visualization for pelvic exams
Pelvic exams are an indispensable part of gynecological care and are used to screen for conditions, such as cervical cancer, that affect millions of patients every year. Unfortunately, pelvic exams can be challenging for ...
Nov 14, 2023
0
37
Simple womb cancer test could reduce need for invasive diagnostic procedures
A new test to detect womb cancer could prevent 87% of women who do not have cancer from needing invasive diagnostic procedures, finds a new study led by researchers at UCL and the University of Innsbruck.
Nov 8, 2023
0
62
ESMO: PARP inhibitor plus immunotherapy lowers risk of endometrial cancer progression over chemotherapy alone
Immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab improved progression-free survival (PFS) in patients with newly diagnosed advanced or recurrent endometrial cancer compared with chemotherapy alone, with further ...
Oct 23, 2023
0
42
